Bachem Holding AG (SWX:BANB)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
57.85
-0.60 (-1.03%)
At close: Mar 5, 2026
3.77%
Market Cap 4.34B
Revenue (ttm) 677.93M
Net Income (ttm) 134.19M
Shares Out 74.97M
EPS (ttm) 1.80
PE Ratio 32.21
Forward PE 29.01
Dividend 0.85 (1.45%)
Ex-Dividend Date May 5, 2025
Volume 87,469
Average Volume 130,252
Open 58.70
Previous Close 58.45
Day's Range 57.40 - 59.30
52-Week Range 43.34 - 76.00
Beta 0.98
RSI 36.55
Earnings Date Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an... [Read more]

Industry Chemicals
Sector Materials
Founded 1971
Employees 2,292
Stock Exchange SIX Swiss Exchange
Ticker Symbol BANB
Full Company Profile

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial Statements

News

There is no news available yet.